Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study

Osteoporosis International

Volumn 17, Issue 5, 2006, Pages 664-671

  Guilera, M ^a   Fuentes, M ^b   Grifols, M ^c   Ferrer, J ^d   Badia, X ^a  

^a Health Outcomes Research Europe   (Spain)

^b Unitat de Recerca del Institut Universitari d'Investigació en Atenció   (Spain)

^c ESTEVE   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Adherence; HRQOL; Osteoporosis; Raloxifene

Indexed keywords

RALOXIFENE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MEDICAL LITERATURE; MULTICENTER STUDY; OSTEOPOROSIS; PAIN; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; FEMALE; HEALTH STATUS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PAMPHLETS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; QUALITY OF LIFE; RALOXIFENE; SPAIN;

EID: 33645779090     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-0031-8     Document Type: Article

References (29)

1. Osteoporosis prevention, diagnosis, and therapy (2001) JAMA 285:785-795
2. Looker AC, Orwoll ES, Johnston CC Jr, et al (1997) Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 12:1761-1768
3. Osteoporosis postmenopausica. Guía de práctica clinica (2003) Rev Clin Esp 203:496-506
4. Diaz CM, Carrasco de la Pena JL, Honorato PJ, et al (1997) Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre research project on Osteoporosis. Osteoporos Int 7:59-64
5. Cook DJ, Guyatt GH, Adachi JD, et al (1999) Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. Osteoporos Int 10:207-213
6. Kado DM, Browner WS, Palermo L, et al (1999) Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:1215-1220
7. Ray NF, Chan JK, Thamer M, et al (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24-35
8. Greendale GA, Barrett-Connor E, Ingles S, et al (1995) Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study. J Am Geriatr Soc 43:955-961
9. Ettinger B, Black DM, Mitlak BH, et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637-645
10. Delmas PD, Ensrud KE, Adachi JD, et al (2002) Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 87:3609-3617
11. Clowes JA, Peel NF, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89:1117-1123
12. Turbi C, Herrero-Beaumont G, Acebes JC, et al (2004) Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther 26:245-256
13. McDonald HP, Garg AX, Haynes RB (2002) Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 288:2868-2879
14. Haynes RB, McDonald HP, Garg AX (2002) Helping patients follow prescribed treatment: clinical applications. JAMA 288:2880-2883
15. Blalock SJ, Currey SS, DeVellis RF, et al (2000) Effects of educational materials concerning osteoporosis on women's knowledge, beliefs, and behavior. Am J Health Promot 14:161-169
16. Blalock SJ, DeVellis BM, Patterson CC, et al (2002) Effects of an osteoporosis prevention program incorporating tailored educational materials. Am J Health Promot 16:146-156
17. Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24:67-74
18. Val JA, Amoros BG, Martinez VP, et al (1992) Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test. Aten Primaria 10:767-770
19. Badia X, Roset M, Montserrat S, et al (1999) The Spanish version of EuroQol: a description and its applications. European quality of life scale. Med Clin 112 [Suppl 1]:79-85
20. Jamal SA, Ridout R, Chase C, et al (1999) Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res 14:2143-2149
21. Farmer KC (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:1074-1090
22. Tosteson AN, Grove MR, Hammond CS, et al (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209-216
23. Papaioannou A, Ioannidis G, Adachi JD, et al (2003) Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int 14:808-813
24. Badia X, Diez-Perez A, Alvarez-Sanz C, et al (2001) Measuring quality of life in women with vertebral fractures due to osteoporosis: a comparison of the OQLQ and QUALEFFO. Qual Life Res 10:307-317
25. Badia X, Diez-Perez A, Lahoz R, et al (2004) The ECOS-16 questionnaire for the evaluation of health related quality of life in post-menopausal women with osteoporosis. Health Qual Life Outcomes 2:41
26. Cote I, Farris K, Feeny D (2003) Is adherence to drug treatment correlated with health-related quality of life? Qual Life Res 12:621-633
27. Billups SJ, Malone DC, Carter BL (2000) The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 20:941-949
28. Holzemer WL, Corless IB, Nokes KM, et al (1999) Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 13:185-197
29. Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M (2000) Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract 17:192-196